Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX
Clinical trial NCT03975790 · COMPLETED
Trial details
- NCT number
- NCT03975790
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-29
- Primary completion
- 2018-10-02
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.